Document Detail


The consequences of iron overdose and its treatment with desferrioxamine in pregnancy.
MedLine Citation:
PMID:  1679648     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A study was carried out to assess the effect on the outcome of pregnancy of iron overdose and its treatment with desferrioxamine. Sixty-eight cases were drawn from those reported to the United Kingdom National Poisons Information Centre and the Teratology Information Service at Guy's Hospital, London, and follow-up was obtained in 51 of these. Two were subsequently reported not to be pregnant and there were 49 records of pregnant patients who took iron overdoses and where outcome of the pregnancy was known. Twenty-five of these patients were treated with desferrioxamine. In 48 of the 49 patients the dose of iron allegedly taken was known and in 28 (60%) was over 20 mg kg-1, sufficient to put them at risk of toxicity. In the 36 whose serum iron levels were measured, 20 patients had levels in excess of 60 mumol l-1, indicating a risk of moderate or severe toxicity. Of the 49 pregnancies, 43 resulted in live babies, two had spontaneous abortions and there were four elective terminations. Of the live babies, three were premature, two of whom had problems, and there were three other babies with abnormalities. All babies with malformations were associated with overdoses after the first trimester and so the malformations cannot be directly related to the overdose. A total of 25 patients received desferrioxamine of whom two had malformed babies, but the desferrioxamine can be excluded as a cause. There was no correlation between the serum iron levels and the birthweights. In conclusion, iron overdose in pregnancy can be fatal and antidote treatment if appropriate should not be withheld.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
P R McElhatton; J C Roberts; F M Sullivan
Related Documents :
1618358 - Pregnancy in idiopathic aplastic anemia (report of 10 patients).
3603108 - Treatment of carpal tunnel syndrome with vitamin b6.
18977808 - Periconceptional maternal vitamin supplementation and childhood leukaemia: an uncertain...
9624108 - Agmatine suppresses proliferation by frameshift induction of antizyme and attenuation o...
22333968 - A comparative study of breastfeeding during pregnancy: impact on maternal and newborn o...
12396558 - The effect of prolonged cryopreservation on embryo survival.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Human & experimental toxicology     Volume:  10     ISSN:  0960-3271     ISO Abbreviation:  Hum Exp Toxicol     Publication Date:  1991 Jul 
Date Detail:
Created Date:  1991-10-17     Completed Date:  1991-10-17     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9004560     Medline TA:  Hum Exp Toxicol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  251-9     Citation Subset:  IM    
Affiliation:
Department of Pharmacology and Toxicology, United Medical School (Guy's Hospital Campus), London, U.K.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Birth Weight
Deferoxamine / therapeutic use*
Female
Humans
Infant, Newborn
Iron / blood,  poisoning*
Male
Overdose / drug therapy,  physiopathology
Pregnancy
Pregnancy Complications / drug therapy*
Pregnancy Outcome
Chemical
Reg. No./Substance:
70-51-9/Deferoxamine; 7439-89-6/Iron

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evidence of soil-pica behaviour and quantification of soil ingested.
Next Document:  Computer prediction of possible toxic action from chemical structure; the DEREK system.